Ceratium are delighted to announce that the VISION DMD pivotal clinical study has been instrumental in paving the way for recommendations to approve of the new steroid-like drug vamorolone to treat Duchenne Muscular Dystrophy (DMD) patients.
On 24th June, the TIGER project held its first workshop at the European Cancer Patient's Coalition Annual congress in Brussels, on 'The role of Biomarkers in personalised Medicine'.
On this rare disease day, we thought It was time to reflect on some of the European Commission’s (EC) success stories from the framework programme.
Results from the ODAK FP7 project have helped leading international ophthalmic company SIFI, take AKANTIOR® closer to becoming the first approved orphan medicinal product for the rare infectious eye disease - Acanthamoeba keratitis.
Ceratium collaborate with a strong European consortium to develop another winning H2020 proposal.